Jaypee Brothers
In Current Chapter
In All Chapters
X
Clear
X
GO
Normal
Sepia
Dark
Default Style
Font Style 1
Font Style 2
Font Style 3
Less
Normal
More
Color Atlas & Synopsis of Pediatric Dermatology
Sandipan Dhar
1:
Basics of Skin and Neonatal Dermatoses
PRIMARY LESIONS
SECONDARY LESIONS
SPECIAL LESIONS
CONFIGURATION OF THE SKIN LESIONS
MONGOLIAN SPOT (Figs 1.2 and 1.2A to C)
Natural History
Management
NEONATAL ACNE (Figs 1.3 to 1.5A)
Management
NEONATAL MILIA (Fig. 1.6)
Natural History
TOXIC ERYTHEMA OF THE NEWBORN (Figs 1.7 to 1.8A)
Differential Diagnosis
Diagnosis
Treatment
INTERTRIGO (Figs 1.9 to 1.9D)
Management
MILIARIA (Figs 1.10 to 10B)
Differential Diagnosis
Management
STAPHYLOCOCCAL SCALDED SKIN SYNDROME (Figs 1.11 and 1.12)
Diagnosis
Prognosis
Management
SUCKLING BLISTER (Fig. 1.13)
Differential Diagnosis
Treatment
NEONATAL HERPES SIMPLEX (Figs 1.14 to 1.16)
Diagnosis
Management
UMBILICAL POLYP (Figs 1.17 and 1.18)
Treatment
UMBILICAL GRANULOMA (Fig. 1.19)
Treatment
CONGENITAL SYPHILIS (Figs 1.20 and 1.21)
Treatment
SUBCUTANEOUS FAT NECROSIS (Figs 1.21A and B)
Differential Diagnosis
Management
SCLEREMA NEONATORUM (Figs 1.22 and 1.23)
Prognosis
Management
HAIRY PINNA (Fig. 1.24)
POLYTHELIA (SUPERNUMERARY NIPPLES) (Fig. 1.25)
Treatment
PHYSIOLOGICAL EXFOLIATION OF NEWBORNS (Figs 1.26 to 1.26B)
Treatment
CUTIS MARMORATA (Figs 1.27 to 1.27B)
Treatment
NEONATAL IRRITANT DERMATITIS (Figs 1.28 and 1.28A)
Diagnosis
Treatment
HARLEQUIN COLOR CHANGES
Diagnosis
Treatment
EPSTEIN’S PEARLS AND BOHN’S NODULES
Diagnosis
Treatment
SEBACEOUS GLAND HYPERPLASIA (Fig. 1.29)
Diagnosis
Treatment
TRANSIENT NEONATAL PUSTULAR MELANOSIS (Figs 1.30 to 1.30B)
Diagnosis
Treatment
ACROPUSTULOSIS OF INFANCY
Diagnosis
Differential Diagnosis
Treatment
CONGENITAL EROSIVE AND VESICULAR DERMATOSIS
Diagnosis
Differential Diagnosis
Treatment
INFANTILE GLUTEAL GRANULOMA (Figs 1.30C and D)
Diagnosis
Treatment
TRICHOSTASIS SPINULOSA (Fig. 1.30E)
APLASIA CUTIS CONGENITA (Figs 1.31 to 1.31C)
Diagnosis
Associations
Differential Diagnosis
Treatment
Venous Prominence Over Bridge of the Nose
Treatment
NEONATAL ERYTHRODERMA (Figs 1.32 to 1.32D)
Cutaneous Disorders
Infections
Immunodeficiency
Metabolic Disorders
Drugs
Diagnosis
Treatment
CARE OF THE NEWBORN SKIN
Need for Special Skin Care for Babies
Care of the Newborn Skin
Skin Care at Birth
Removal of Vernix Caseosa
Washing and Bathing
Napkin Changes
Scalp
Nails
Ears
Umbilicus
Skin Care in the Premature Infants
Preventive Measures
Disinfection
Incubator
Transcutaneous Oxygen Monitors
Minimal Use of Tape and Adhesive
Emollients
Skin Care of the Term Baby and Infant
Detergents
Protective Creams
Powders
Role of Massage
2:
Vascular, Melanocytic and Other Nevi
SALMON PATCH (Figs 2.1 and 2.1A)
Natural History
Management
HEMANGIOMA (Figs 2.2 to 2.6J)
Natural History
Management
KLIPPEL–TRENAUNAY SYNDROME AND PARKES WEBER SYNDROME (Figs 2.7 to 2.9A)
Complications
Treatment
PHACES SYNDROME (Fig. 2.9B)
STURGE–WEBER SYNDROME (Figs 2.9C)
ANGIOKERATOMA CIRCUMSCRIPTUM (Figs 2.10 and 2.11)
Natural History
Treatment
PYOGENIC GRANULOMA (Figs 2.11A to B)
Treatment
Glomus Tumor
DIFFERENTIAL DIAGNOSES
Treatment
TELANGIECTASIA (Figs 2.11C and D)
GENERALIZED ESSENTIAL TELANGIECTASIA (Fig. 2.11E)
ATAXIA TELANGIECTASIA (Figs 2.11F and G)
PIGMENTED PURPURIC DERMATOSES (Figs 2.11H to K)
PURPURA FULMINANS (Figs 2.11L and M)
LYMPHANGIOMA CIRCUMSCRIPTUM (Figs 2.12 to 2.14A)
Treatment
LYMPHEDEMA (Fig. 2.14B)
Primary Lymphedema (Intrinsic Defects in Lymphatic Channels)
Secondary Lymphedema
NEVUS OF OTA AND ITO (Figs 2.15 and 2.16B)
Management
MELANOCYTIC NEVUS (Figs 2.17 to 2.20F)
Natural History
Systemic Associations
Management
BECKER’S NEVUS (Figs 2.20G and 2.20H)
Etiology
Treatment
LENTIGINES (Fig. 2.21)
Natural History
Treatment
LEOPARD SYNDROME (Fig. 2.22)
FRECKLES (EPHELIDES) (Figs 2.22A and 2.22B)
Treatment
NEVUS SPILUS (Figs 2.22C and 2.22D)
PEUTZ–JEGHERS SYNDROME (Figs 2.23 to 2.26)
Management
EPIDERMAL NEVI (Figs 2.26A to 2.26I)
Treatment
INFLAMMATORY LINEAR VERRUCOUS EPIDERMAL NEVUS (ILVEN) (Figs 2.27 and 2.27A)
Management
NEVUS SEBACEOUS (Figs 2.28 to 2.28C)
Systemic Associations
Treatment
NEVUS COMEDONICUS (Figs 2.29 and 2.29A)
Natural History
Management
3:
Genodermatoses
ECTODERMAL DYSPLASIA (Figs 3.1 to 3.4)
ANHIDROSIS
Treatment
Management
PALMOPLANTAR KERATODERMAS
DIFFUSE KERATODERMAS
Epidermolytic and Nonepidermolytic Palmoplantar Keratoderma (Figs 3.4 to 3.4C)
Vohwinkle Syndrome (Fig. 3.4D)
Clouston Syndrome
Mal De Meleda (Figs 3.4E and F)
Olmsted Syndrome (Fig. 3.4G and H)
Focal Keratodermas
Pachyonychia Congenita (Figs 3.4I to M)
Richner-Hanhart Syndrome
Howel Evans Syndrome
Papillon-Lefevre Syndrome (Fig. 3.4N)
PUNCTATE PALMOPLANTAR KERATODERMA
ERYTHROKERATODERMAS
Erythrokeratoderma Variabilis (Figs 3.4O to Q)
Treatment
Progressive Symmetric Erythrokeratoderma (Figs 3.4R and S)
XERODERMA PIGMENTOSUM (Figs 3.5 to 3.8A)
Natural History
Treatment
Pigmented Xerodermoid (Figs 3.8B to D)
PSEUDOXANTHOMA ELASTICUM (Figs 3.9 and 3.10)
Systemic Associations
Management
CUTIS LAXA (Figs 3.10A to C)
DARIER’S DISEASE (Figs 3.11 to 3.13A)
Management
PROGERIA (Figs 3.14 to 3.18)
Prognosis
KINDLER SYNDROME (Figs 3.19 to 3.22)
Prognosis
Treatment
4:
Disorders of Keratinization
ICHTHYOSIS VULGARIS (Figs 4.1 to 4.2A)
Natural History
Management
X-LINKED RECESSIVE ICHTHYOSIS (Figs 4.3 to 4.3C)
Systemic Associations
Natural History
Treatment
LAMELLAR ICHTHYOSIS (LI) (Figs 4.4 to 4.5A)
Management
NONBULLOUS ICHTHYOSIFORM ERYTHRODERMA (Figs 4.6 to 4.9C)
Management
EPIDERMOLYTIC HYPERKERATOSIS (BULLOUS ICHTHYOSIFORM ERYTHRODERMA) (Figs 4.10 to 4.13A)
Differential Diagnosis
Management
COLLODION BABY (Figs 4.14 to 4.19A)
Complications
Treatment
HARLEQUIN FETUS (Figs 4.20 to 4.20C)
Natural History
Complications
Treatment
PITYRIASIS RUBRA PILARIS (Figs 4.21 to 4.24C)
Treatment
KID SYNDROME (Figs 4.25 to 4.25B)
Treatment
NETHERTON SYNDROME (Figs 4.26 to 4.26C)
SJÖGREN-LARSSON SYNDROME
REFSUM DISEASE
Diagnosis
Treatment
CONRADI-HÜNERMANN-HAPPLE SYNDROME
Treatment
CHILD SYNDROME
PEELING SKIN SYNDROME (Figs 4.26D and E)
HAILEY-HAILEY DISEASE (Figs 4.27 to 4.27C)
Etiology
Clinical Features
Differential Diagnoses
Treatment
POROKERATOSIS (Figs 4.28 to 4.30)
Etiopathogenesis
Treatment
5:
Infections and Infestations
SCABIES (Figs 5.1 to 5.3C)
Complications
Treatment
PEDICULOSIS
Pediculosis Capitis (Figs 5.3D and E) (Head Louse Infestation)
Pediculosis Corporis (Figs 5.3F and G) (Body Louse Infestation)
Pediculosis Pubis (Fig. 5.3H)
Furunculosis (Figs 5.4 and 5.5)
Folliculitis (Figs 5.5A to C)
Etiology
CLINICAL FEATURES
Superficial Folliculitis
Periporitis (Figs 5.5D to F)
Differential Diagnosis
Laboratory Diagnosis
IMPETIGO (Figs 5.6 to 5.8C)
ECTHYMA (Figs 5.9 to 5.10B)
Ecthyma Gangrenosum
CELLULITIS AND ERYSIPELAS (Figs 5.11 to 5.11B)
Complications
Treatment
ACUTE LYMPHANGIITIS (Fig. 5.12)
Differential Diagnosis
SYCOSIS BARBAE (Figs 5.12A and B)
Etiology
Management
CARBUNCLE (Figs 5.12C and D)
Clinical Features
Differential Diagnosis
Laboratory Diagnosis
Treatment
NECROTIZING FASCIITIS (Figs 5.12E to G)
Diagnosis
Treatment
NOMA (Figs 5.12H AND I)
Etiopathogenesis
Clinical Feature
Treatment
ERYTHRASMA (Fig. 5.12J)
Etiology
Clinical Features
Differential Diagnosis
Laboratory Diagnosis
Treatment
Systemic Therapy
Topical Therapy
PITTED KERATOLYSIS (Figs 5.12K and L)
Etiology
Cinical Features
Differential Diagnosis
Laboratory Diagnosis
Treatment
PERIANAL STREPTOCOCCAL DERMATITIS (Fig. 5.12M)
Etiology
Clinical Features
Differential Diagnosis
Laboratory Diagnosis
Treatment
BLISTERING DISTAL DACTYLITIS (Fig. 5.12N)
Etiology
Clinical Features
Differential Diagnosis
Laboratory Diagnosis
Treatment
LUPUS VULGARIS (Figs 5.13 to 5.13C)
SCROFULODERMA (Figs 5.14A to D)
TUBERCULOSIS VERRUCOSA CUTIS (Figs 5.14E to H)
LUPUS MILIARIS DISSEMINATUS FACIEI (Figs 5.14I and 5.14J)
Treatment
LEPROSY
INDETERMINATE LEPROSY (Figs 5.15 and 5.15A)
BORDERLINE TUBERCULOID LEPROSY (Figs 5.16 to 5.17D)
BORDERLINE LEPROMATOUS LEPROSY (Fig. 5.17E)
LEPROMATOUS LEPROSY (Figs 5.17F to K)
Clinical Features
Differential Diagnosis of Facial Infiltration
Laboratory Diagnosis
HISTOID LEPROSY (Figs 5.17L to N)
Clinical Features
Differential Diagnosis
Laboratory Diagnosis
Treatment
MB Child Treatment (10–14 Years)
COMMON WARTS (VERRUCA VULGARIS) (Figs 5.18 and 5.19A to D)
Natural History
Treatment
VERRUCA PLANA (Figs 5.19E and F)
Treatment
Differential Diagnosis
MOLLUSCUM CONTAGIOSUM (Figs 5.20 to 5.24C)
Treatment
PITYRIASIS ROSEA (Figs 5.25 and 5.26)
Natural History
Treatment
HERPES SIMPLEX INFECTION (Figs 5.27 to 5.30)
Herpetic Gingivostomatitis
Herpes Genitalis
Keratoconjunctivitis
HERPES ZOSTER (Figs 5.31 to 5.33A)
Treatment
TINEA CORPORIS AND TINEA FACIEI (Figs 5.34 to 5.36)
Management
TINEA CAPITIS (Figs 5.37 to 5.40)
Etiology
Pathogenesis
Clinical Features
Differential Diagnosis
Laboratory Diagnosis
Treatment
TINEA PEDIS AND TINEA MANUM (FIGS 5.40A TO C)
Diagnosis
Treatment
PITYRIASIS VERSICOLOR (Figs 5.41 and 5.42)
Treatment
PARONYCHIA (Figs 5.43 and 5.44)
Treatment
CANDIDIASIS OF SKIN (Fig. 5.44A)
CHRONIC MUCOCUTANEOUS CANDIDIASIS(CMC) (Figs 5.45 to 5.50)
Etiopathogenesis
Clinical Features
Differential Diagnosis
MEDIAN RHOMBOID GLOSSITIS (Figs 5.50A and 5.50B)
Laboratory Diagnosis
Treatment
NOCARDIOSIS
Clinical Features
Laboratory Investigations
Differential Diagnoses
Treatment
ACTINOMYCOSIS
Clinical Features
Investigations
Differential Diagnoses
Treatment
LEISHMANIASIS (Figs 5.51 and 5.52)
Etiology
Clinical Features
Differential Diagnosis
Laboratory Diagnosis
Treatment
6:
Exanthems of Infective Etiology
MEASLES (RUBEOLA) (Figs 6.1 to 6.3)
Prophylaxis
GERMAN MEASLES (RUBELLA) (Figs 6.4 and 6.5)
Prophylaxis
CONGENITAL RUBELLA (Fig. 6.6)
Prophylaxis
VARICELLA (CHICKENPOX) (Figs 6.7 to 6.9)
BREAK THROUGH VARICELLA (Figs 6.9A and B)
Management
DENGUE FEVER (Figs 6.10 to 6.15)
Diagnosis
Management
GIANOTTI-CROSTI SYNDROME (Figs 6.15A to 6.15E)
Etiology
Treatment
STAPHYLOCOCCAL SCALDED SKIN SYNDROME (Figs 6.16 and 6.17)
Prognosis
Treatment
KAWASAKI DISEASE (Figs 6.17A to 6.17O)
Etiopathogenesis
Clinical Features
Cutaneous Manifestations
Systemic Associations
Diagnostic Criteria for Kawasaki Syndrome
Laboratory Diagnosis
Differential Diagnosis
Treatment
TOXIC SHOCK SYNDROME (Fig. 6.18)
Treatment
CHIKUNGUNYA FEVER (Figs 6.19 to 6.19D)
Etiology
Clinical Features
Investigations
Treatment
RICKETTSIAL DISEASES (Figs 6.20 to 6.24)
Etiopathogenesis
Clinical Features
Differential Diagnosis
Laboratory Diagnosis
Treatment
Specific Therapy
Supportive Therapy
HAND-FOOT AND MOUTH DISEASE (Figs 6.25 to 6.33)
7:
Eczema and Dermatitis
NAPKIN DERMATITIS (Figs 7.1 to 7.2A)
JACQUET’S DERMATITIS (Fig. 7.2B)
Management
IRRITANT DERMATITIS (Figs 7.3 and 7.3A)
Treatment
LIPLICKER’S DERMATITIS (Figs 7.3B to 7.3D)
Treatment
CRADLE CAP (Fig. 7.4 to 7.4B)
Treatment
INFANTILE SEBORRHEIC DERMATITIS (Figs 7.5 to 7.7)
Differential Diagnosis
Treatment
PAPULAR URTICARIA (PU) (Figs 7.8 to 7.9C)
Complication
Treatment
NODULAR PRURIGO (Figs 7.10 to 7.10C)
Treatment
ATOPIC DERMATITIS (Figs 7.11 to 7.30D)
Clinical Features
INFANTILE PHASE (Figs 7.31 to 7.31B)
CHILDHOOD PHASE (Figs 7.32 to 7.32C)
Infected Lesions of AD
ADULT PHASE (Fig. 7.34)
Atopic Hand Eczema
Associated Disorders
PITYRIASIS ALBA (Figs 7.15 to 7.15B)
KERATOSIS PILARIS (Figs 7.16 and 7.16A)
DENNIE-MORGAN FOLDS (Figs 7.17 and 7.17A)
GEOGRAPHIC TONGUE (BENIGN MIGRATORY GLOSSITIS) (Figs 7.18A and 7.18B)
JUVENILE PLANTAR DERMATITIS (Figs 7.19 and 7.20)
POMPHOLYX (Figs 7.21 and 7.21A)
SEVERE ATOPIC DERMATITIS (Figs 7.35A to 7.35E)
POSTERIOR THIGH DERMATITIS (Figs 7.35F to H)
Treatment
Atopic Dermatitis Like Eczemas
Wiskott-Aldrich Syndrome
Hyperimmunoglobulinemia E Syndrome (HIES)
Severe Combined Immunodeficiency
Phenylketonuria (PKU)
INFECTIOUS ECZEMATOID DERMATITIS (Figs 7.36 and 7.37A)
Treatment
MILIARIAL ECZEMA (Figs 7.38 to 7.40)
Treatment
ALLERGIC CONTACT DERMATITIS (Figs 7.41 to 7.44)
8:
Papulosquamous Disorders
INFANTILE AND CHILDHOOD PSORIASIS (Figs 8.1 to 8.9A)
Guttate Psoriasis (Figs 8.9B and C)
Diaper Psoriasis (Fig. 8.9D)
Scalp Psoriasis (Figs 8.9E to G)
Nail Psoriasis (Figs 8.9H and I)
Erythrodermic Psoriasis (Figs 8.9J to M)
Extracutaneous Involvement in Psoriasis
Drug Induced Psoriasis
Drugs Responsible for the Induction of Psoriasis
INFANTILE AND JUVENILE PUSTULAR PSORIASIS (Figs 8.9N to 8.12)
Topical Treatment
Systemic Therapy
LICHEN PLANUS (Figs 8.13 to 8.16H)
Association
Natural History
Treatment
ROLE OF CYCLOSPORINE IN LICHEN PLANUS
ROLE OF ORAL RETINOIDS IN LICHEN PLANUS
LICHEN NITIDUS (Figs 8.17 to 8.18)
Natural History
Treatment
9:
Vesiculobullous Diseases
CHRONIC BULLOUS DERMATOSIS OF CHILDHOOD (Figs 9.1 to 9.4B)
Natural History
Treatment
CICATRICIAL PEMPHIGOID (Figs 9.5A to D)
Diagnosis
Treatment
DERMATITIS HERPETIFORMIS (Fig. 9.5E to G)
Treatment
EPIDERMOLYSIS BULLOSA (Figs 9.6 to 9.16D)
Management
FUTURE THERAPIES OF EPIDERMOLYSIS BULLOSA
PEMPHIGUS VULGARIS AND PEMPHIGUS FOLIACEUS (Figs 9.17 to 9.22A)
DRUG INDUCED PEMPHIGUS
Diagnosis
Treatment
SUBCORNEAL PUSTULAR DERMATOSES (Figs 9.23 to 9.26)
10:
Neurocutaneous Disorders
TUBEROUS SCLEROSIS COMPLEX (Figs 10.1 to 10.6A)
Primary Features
Secondary Features
Tertiary Features
Angiofibroma
Periungual Fibromas
Shagreen Patch
Ash-Leaf Macules
NEUROFIBROMATOSIS AND CAFÉ-AU-LAIT MACULES (Figs 10.7 to 10.8C)
Management
MCCUNE ALBRIGHT SYNDROME (Fig. 10.9)
INCONTINENTIA PIGMENTI (Figs 10.10 to 10.12)
Systemic Association
Treatment
HYPOMELANOSIS OF ITO (Figs 10.12A to 10.13)
Treatment
PIGMENTARY MOSAICISM (Fig. 10.13A)
FAUN TAIL NAEVUS (Fig. 10.14)
Treatment
MENINGOMYELOCELE (Figs 10.15 and 10.16)
11:
Pigmentary Disorders
VITILIGO (Figs 11.1A to 11.4C)
Prognosis
Differential Diagnosis
Treatment
CHEMICAL (CONTACT) LEUKODERMA (Figs 11.4D to G)
HALO NEVUS (Figs 11.4G1 to I)
Treatment
IDIOPATHIC GUTTATE HYPOPIGMENTATION (Figs 11.4J to L)
NEVUS DEPIGMENTOSUS (Figs 11.5 to 11.6A)
Treatment
NEVUS ANEMICUS (Fig. 11.7 and 11.7A)
Treatment
LICHEN SCLEROSUS ET ATROPHICUS (Figs 11.8 to 11.8G)
Diagnosis
Treatment
POST KALA-AZAR DERMAL LEISHMANIASIS (PKDL) (Fig. 11.9)
Management
ALBINISM (Figs 11.10 to 11.13)
Complications
Management
LICHEN STRIATUS (Figs 11.14 and 11.14E)
Natural History
Differential Diagnosis
Treatment
POST-INFLAMMATORY HYPOPIGMENTATION (Figs 11.15 to 11.16A)
Natural History
Treatment
POST-INFLAMMATORY HYPERPIGMENTATION (Figs 11.17 to 11.17B)
Natural History
Treatment
HYPERPIGMENTATION DUE TO ADDISON’S DISEASE (Figs 11.18 to 11.20i)
FAMILIAL HYPERPIGMENTATION OF TONGUE (Figs 11.20A to 11.20D)
Management
HYPERPIGMENTATION OF KNUCKLE AND DORSAL ASPECT OF INTERPHALANGEAL JOINTS OF FINGERS IN ATOPICS (Figs 11.21 to 11.24)
IDIOPATHIC ERUPTIVE MACULAR HYPERPIGMENTATION (Figs 11.25 to 11.27)
Differential Diagnoses
DYSCHROMATOSIS HEREDITARIA (Figs 11.28 and 11.29)
RETICULATE ACROPIGMENTATION OF KITAMURA (Figs 11.30 and 11.31)
PIGMENTARY DEMARCATION LINES (Figs 11.32 to 11.37A)
12:
Nutritional Deficiency Disorders
ACRODERMATITIS ENTEROPATHICA (Figs 12.1 and 12.2H)
Diagnosis
Treatment
KAWASHIORKOR (Figs 12.3 and 12.4ii)
Natural History
Management
MARASMUS (Figs 12.4A to E)
PHRYNODERMA (Figs 12.5 to 12.5B)
Diagnosis
VITAMIN B2 (RIBOFLAVIN) DEFICIENCY (Figs 12.6 and 12.7)
VITAMIN B12 (CYANOCOBALAMIN) DEFICIENCY (Figs 12.8 to 12.10)
Diagnosis
Treatment
PELLAGRA (Figs 12.11 and 12.12)
Treatment
BIOTINIDASE DEFICIENCY (Figs 12.13 and 12.14)
13:
Urticaria, Mast Cell and Histiocytic Disorders
URTICARIA (Figs 13.1 to 13.3D)
ANGIOEDEMA (Figs 13.3E to G)
DERMOGRAPHISM (Figs 13.4 to 13.4iii)
Management
MASTOCYTOSIS
SOLITARY MASTOCYTOMA (figs 13.4A to D)
Prognosis
URTICARIA PIGMENTOSA (Figs 13.5 to 13.7B)
DIFFUSE CUTANEOUS MASTOCYTOSIS (Figs 13.8 to 13.9C)
Diagnosis
Treatment
LANGERHANS CELL HISTIOCYTOSIS
LETTERER-SIWE DISEASE (Figs 13.10 to 13.12C)
Treatment
HAND-SCHüLLER-CHRISTIAN DISEASE
EOSINOPHILIC GRANULOMA (Fig. 13.13)
Natural History
Management
BENIGN CEPHALIC HISTIOCYTOSIS (Fig. 13.14)
Differential Diagnoses
Management
DERMATOFIBROMA (Fig. 13.15 to 13.16A)
14:
Metabolic Disorders
ALKAPTONURIA (Figs 14.1 and 14.2)
Clinical Features
Investigations
Treatment
Differential Diagnoses
Management
ADDISON’S DISEASE (Figs 14.2A and B)
Clinical Features
Cutaneous Manifestations
Diagnosis
Treatment
DIABETIC DERMOPATHY (Fig. 14.2C)
NECROBIOTIC LIPOIDICA DIABETICORUM (NLD) (Fig. 14.2D and E)
CUSHING’S DISEASE (Fig. 14.2F to H)
Clinical Features
Investigations
Differential Diagnosis
Treatment
DIABETIC BULLA (Fig. 14.2I and J)
XANTHOMA (Figs 14.3 to 14.5)
Differential Diagnosis
Treatment
JUVENILE XANTHOGRANULOMA (Figs 14.5A to D)
Natural History
Systemic Associations
Treatment
CONGENITAL ERYTHROPOIETIC PORPHYRIA (GUNTHER’S DISEASE) (Figs 14.6 to 14.9)
Prognosis
Treatment
FABRY’S DISEASE (Fig. 14.10)
Systemic Associations
Treatment
FARBER’S DISEASE (Fig. 14.11)
Diagnosis
Prognosis
Treatment
LESCH-NYHAN SYNDROME (Figs 14.12 and 14.13)
Management
CALCIPHYLAXIS (Figs 14.14 to 14.16)
15:
Collagen Vascular Diseases and Vasculitis
DISCOID LUPUS ERYTHEMATOSUS (Figs 15.1 to 15.7A)
Management
LUPUS ERYTHEMATOSUS (Figs 15.7B to D)
Acute Cutaneous Lupus Erythematosus (ACLE)
Subacute Cutaneous Lupus Erythematosus (SCLE)
Chronic Cutaneous Lupus Erythematosus (Discoid Lupus Erythematosus)
Pathogenesis of Cutaneous Lupus Erythematosus
Chronic Cutaneous Lupus Erythematosus
Discoid Lupus Erythematosus
Hypertrophic Type
Lichenoid Discoid Lupus Erythematosus
Lupus Erythematosus Telangiectodes
Lupus Erythematosus Linearis
Pigmented Lupus Erythematosus
LE Panniculitis
Chillblain Lupus Erythematosus
Lupus Erythematosus Tumidus
Rowell Syndrome
Investigations
Treatment
SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS (Figs 15.7E and F)
Treatment
ACUTE CUTANEOUS LUPUS ERYTHEMATOSUS
Localized Acute Cutaneous Lupus Erythematosus
Generalized Acute Cutaneous Lupus Erythematosus
Lupus Erythematosus Nonspecific Lesions
Bullous LE
Treatment
NEONATAL LUPUS ERYTHEMATOSUS (Figs 15.7G to I)
Role of Antibodies in the Pathogenesis
Other Factors
Clinical Features
Cutaneous Manifestations
Cardiac Manifestations
Other Systemic Involvement
Diagnosis
Prenatal Screening
Differential Diagnoses
Treating Fetal Heart Block
Course and Outcome
DERMATOMYOSITIS (Figs 15.8 to 15.12i)
Management
PROGRESSIVE SYSTEMIC SCLEROSIS (Figs 15.12A to Diii)
Management
MORPHEA (Figs 15.12E to G)
Natural History
Treatment
PARRY-ROMBERG SYNDROME AND LINEAR SCLERODERMA (Figs 15.12H to N)
NECROTIZING VASCULITIS (Figs 15.13 to 15.17)
LIVEDOID VASCULITIS (Figs 15.18 to 15.20)
Treatment
POLYARTERITIS NODOSA (Figs 15.20A to 15.22)
Natural History
Prognosis
Management
PITYRIASIS LICHENOIDES (Figs 15.22A to 15.22F)
Etiology
Clinical Features
Differential Diagnosis
Treatment
ANTIPHOSPHOLIPID ANTIBODY SYNDROME (Fig. 15.23)
HENOCH SCHONLEIN PURPURA (Figs 15.24 to 15.26)
IDIOPATHIC THROMBOCYTOPENIC PURPURA (Figs 15.27 and 15.28)
16:
Diseases of Hair and Nail
ALOPECIA AREATA (Figs 16.1 to 16.4I)
Natural History
Treatment
SCARRING ALOPECIA (Fig. 16.5)
Treatment
PSEUDOPELADE (Figs 16.5A and B)
Treatment
SEBORRHEIC ALOPECIA (Fig. 16.6)
TRICHOTILLOMANIA (Figs 16.6A to D)
Management
OCCIPITAL ALOPECIA (Figs 16.6A, 16.7 and 16.7B)
WOOLY HAIR (Figs 16.8 to 16.8B)
MONILETHRIX (BEADED HAIR) (Figs 16.9 to 16.9B)
Pseudomonilethrix
PIEBALDISM (Figs 16.10 to 16.10D)
Natural History
Treatment
PREMATURE CANITIES (PREMATURE GRAYING) (Figs 16.11 and 16.12)
Management
PITYRIASIS AMIANTACEA (TINEA AMIANTACEA) (Figs 16.12A and B)
Treatment
NEONATAL HAIR (Fig. 16.12C)
ANAGEN EFFLUVIUM (Figs 16.12D and E)
ANDROGENETIC ALOPECIA (Figs 16.12F to H)
Management
TELOGEN EFFLUVIUM
ACQUIRED PROGRESSIVE KINKING OF THE HAIR [FIGS 16.12I(I) AND (II)]
PILI TORTI (Fig. 16.12J)
Pili Annulati
TRICHORRHEXIS NODOSA (Fig. 16.12K)
Clinical Features
Differential Diagnosis
Investigation
Management
Trichothiodystrophy
Trichorrhexis Invaginata
UNCOMBABLE HAIR SYNDROME (Fig. 16.12L)
Loose Anagen Syndrome
Hypertrichosis
Congenital Hypertrichosis (Fig. 16.12M)
Hypertrichosis Lanuginosa [Fig. 16.12M(i)]
Ambras Syndrome
X-linked Dominant Hypertrichosis
Generalized Hypertrichosis (Fig. 16.12N)
Hypertrichosis with Gingival Hyperplasia
Nevoid Hypertrichosis (Fig. 16.12O)
Hypertrichosis
IDIOPATHIC HYPERTRICHOSIS (Figs 16.12P to S)
Treatment
HIRSUTISM (Figs 16.12T to V)
Silvery Gray Hair Syndromes
GRISCELLI SYNDROME (Figs 16.13 to 16.13C)
CHEDIAK-HIGASHI SYNDROME (Figs 16.14 to 16.14C)
Elejalde Syndrome
CUTIS VERTICES GYRATA (Figs 16.14D and E)
PUNCTATE LEUKONYCHIA (Figs 16.15 to 16.17)
TOTAL LEUKONYCHIA (Fig. 16.18)
YELLOW NAIL SYNDROME (Fig. 16.18A)
BEAU’S LINE (Fig. 16.18B)
KOILONYCHIA
ONYCHOGRYPHOSIS [Figs 16.18B(i) and 16.18B(ii)]
MEDIAN NAIL DYSTROPHY (DYSTROPHIA UNGUIS MEDIANA CANALIFORMIS) (Figs 16.18C and D)
ONYCHOLYSIS (Figs 16.18E(i) and E(ii)
INGROWING TOENAIL (ONYCHOCRYPTOSIS) (Figs 16.18F to H)
HABIT TIC DYSTROPHY (Figs 16.18I and J)
PTERYGIUM UNGUIS (Fig. 16.18K)
MELANONYCHIA STRIATA (Figs 16.18L and M)
MUEHRCKE’S NAILS (Fig. 16.19)
TWENTY NAIL DYSTROPHY (TND) (Figs 16.20 and 16.20A)
NAIL SHEDDING OR ONYCHOMADESIS (Figs 16.21 to 16.23)
ONYCHOMYCOSIS (Figs 16.24 and 16.25)
17:
Acne, Rosacea and Hidradenitis Suppurativa
VARIOUS TYPES OF ACNE
ACNE VULGARIS (Figs 17.1 and 17.2E)
Management
ACNEIFORM ERUPTIONS (Figs 17.3A to C)
Treatment
PERIORAL DERMATITIS (Figs 17.3D and E)
ACNE EXCORIéE (Figs 17.4A to D)
ACNE KELOIDALIS NUCHAE (Figs 17.4E and F)
Etiopathogenesis
Cutaneous Examination
Differential Diagnosis
Investigations
Management
ROSACEA (Figs 17.5 to 17.6A)
Treatment
Role of Rifaximin in Rosacea
HIDRADENITIS SUPPURATIVA (Figs 17.7 to 17.8A)
Treatment
PITYROSPORUM FOLLICULITIS (Figs 17.9 and 17.10)
Etiology
Treatment
Natural History
FOX FORDYCE’S DISEASE (Fig. 17.11)
18:
Adverse Drug Eruptions
EPIDEMIOLOGY AND THE ROLE OF RISK FACTORS
ETIOPATHOGENESIS
Gell and Coombs Classification of Immunological Reactions
DIAGNOSTIC WORK UP
MACULOPAPULAR ERUPTIONS (Figs 18.1 to 18.1C)
Differential Diagnosis
Drug Responsible
Treatment
FIXED DRUG ERUPTION (Figs 18.2 to 18.4B)
Drug Responsible
Treatment
ERYTHEMA MULTIFORME (Figs 18.5 to 18.9)
STEVENS–JOHNSON SYNDROME (Figs 18.10 to 18.12A)
Drug Responsible
TOXIC EPIDERMAL NECROLYSIS (LYELL’S SYNDROME) (Figs 18.13 to 18.14A)
Drug Responsible
MANAGEMENT PROTOCOL FOR SJS-TEN
SERUM SICKNESS (Fig. 18.15)
Treatment
DRESS SYNDROME (Figs 8.15A and B)
TOXIC PALMAR ERYTHEMA AND FISSURING OF PALMS (Figs 18.16 to 18.18)
Pathogenesis
Clinical Features
Diagnosis
Treatment
19:
Striae and Scars
IDIOPATHIC STRIAE DISTENSAE (Figs 19.1 to 19.3A)
Natural History
Treatment
HYPERTROPHIC SCAR (Figs 19.3B to D)
KELOID (Figs 19.4 to 19.4C)
Treatment
TOPICAL STEROID INDUCED CUTANEOUS ATROPHY (Figs 19.5 to 19.6)
VERMICULATE ATROPHODERMA OF THE FACE (Figs 19.7 and 19.8)
ANETODERMA (Fig. 19.9)
20:
Miscellaneous Dermatoses
ACANTHOSIS NIGRICANS (AN) (Figs 20.1 and 20.2B)
Benign Forms
Malignant Forms
Natural History
Treatment
DYSKERATOSIS CONGENITA (Figs 20.3 to 20.6)
Natural History
Treatment
WISKOTT-ALDRICH SYNDROME (Figs 20.7A to 20.8A)
Management
INFANTILE DIGITAL FIBROMATOSIS (IDF) (Figs 20.9 to 20.12)
Natural History
Treatment
ERYTHEMA NODOSUM (Figs 20.13 to 20.15)
Etiology
Drugs Responsible
Treatment
FRICTIONAL LICHENOID DERMATITIS (FLD) (Figs 20.16 and 20.17)
Treatment
SWEET’S SYNDROME (Figs 20.18 to 20.19)
Treatment
PALMOPLANTAR HYPERHIDROSIS (Figs 20.20 and 20.21)
Treatment
MILIA (Figs 20.22 to 20.24)
Treatment
CHRONIC ARSENIC POISONING (Figs 20.25 to 20.28)
Etiology and Epidemiology
Clinical Features
Differential Diagnoses
Treatment
FORDYCE’S SPOTS (Figs 20.29 and 20.30)
POLYMORPHOUS LIGHT ERUPTION (Figs 20.31 to 20.35A)
Etiology
Clinical Features
Diagnosis
Treatment
DERMATITIS ARTEFACTA (Figs 20.40 and 20.41)
APHTHOUS ULCERS (Figs 20.42 to 20.45)
BEHÇET’S DISEASE (Figs 20.46 and 20.47)
RIETER’S DISEASE (Figs 20.48 and 20.52)
MUCOSAL CYST (Fig. 20.53)
GRANULOMA ANNULARE (Figs 20.54 and 20.55)
TRICHOEPITHELIOMA (Fig. 20.56)
BILATERAL SYMMETRICAL LIVIDITY (Figs 20.57 and 20.58)
21:
Sexually Transmitted Diseases, Patient Education and Counseling
CHANCRE OF PRIMARY SYPHILIS (Fig. 21.1)
CONDYLOMA ACUMINATA (Figs 21.2 and 21.3)
HERPES GENITALIS INFECTION (Figs 21.4 and 21.5)
Difficulties with Pediatric Patient Education and Counseling
Advantages of Patient Education and Counseling
Types and Method of Patient Education and Counseling
CONCLUSION
Bibliography
INDEX
TOC
Index
×
Chapter Notes
Save
Clear